DNAFORM was established by the Institute of Physical and Chemical Research (headquartered in Wako, Saitama; Shunichi Kobayashi, President) in September 1998, in order to carry out genome related research and development. It was established under a special venture system created to allow the Institute's research results to be used for starting businesses. DNAFORM is engaged in biotechnology development business including gene function analysis, as well as research support services. Its technology is based on complete-length cDNA manufacturing patents gained from research at the Institute of Physical and Chemical Research.

Internationally, DNAFORM is considered to be at the forefront of applied technology relating to complete-length cDNA. Through this investment by MCC., DNAFORM becomes the first real genome related venture in Japan. By launching business activities for manufacturing using complete-length cDNA, it is expected that new employment opportunities for researchers will be immediately created.

In recent years rapid advances in genome studies have been made around the world. It is expected that these advances will be utilized across many areas of medical treatment in the future. MCC Group has been carrying out life science research for about 30 years, and has been successful in pharmaceuticals and other related businesses. In the future however, the company will be covering an even wider area of technology, and needs to have support from the outside in order to develop new businesses.

In Europe and North America, venture-capital companies serve to bridge the gap between technology produced by research institutions and the application of the same technology by private companies. Major pharmaceutical and chemical companies are providing investment for this kind of R&D venture enterprise especially in the field of genome studies. Likewise, MCC Group has decided to invest in DNAFORM in a move to help strengthen its life science division.

DNAFORM's special Institute-venture status will not be affected by the tie-up. DNAFORM will continue to follow their own paths for business and technological information management.